New Development - Biologics (The New Asthma Treatment)

The whole biologics space as a new treatment regime is very exciting especially for chronic asthmatics. Whilst the treatment is cutting edge and used to great benefit and positive effect in other chronic conditions and diseases including, MS, Cancers, Rheumatoid Arthritis, the cost for treatment can be quite high ($500 - $1,500 per month).

Asthma Australia recently announced today as per the link below that the biolgics treatment for asthmatics has been approved for the PBS. This is truly great news for RSH and moderate to chronic asthmatics as it potentially reduces the price of the biologic from $500 - $1,500 per month to $40 per month and locks in Wheezo as the reduced price comes with the requirement for ongoing monitoring and measurement of a patients symptoms and condition to confirm improved patient and health outcomes.

Seemingly 2 very tangible benefits of Wheezo for Pharma company with Biologic: -

• Wheezo can objectively measure asthmatics symptom & condition to confirm non-management of condition and ineffectiveness of current medication program - 70% of asthmatics believe their symptoms are well controlled when they are not; more biologics to more asthmatics who need them.
• Wheezo can objectively measure the effectiveness of a biologic treatment program in an asthmatic and show evidence that the biologic improves patient outcomes with the guidance of a health professional (Doctor) and allows lower price under PBS.

https://asthma.org.au/about-us/media/life-changing-biologics-therapies-made-more-accessible-to-people-with-severe-asthma/